Yayınlar & Eserler

Yayın Ağı
Makaleler 38
Tümü (38)
SCI-E, SSCI, AHCI (31)
SCI-E, SSCI, AHCI, ESCI (35)
ESCI (4)
Scopus (33)
TRDizin (11)

1. Ustekinumab may have therapeutic effects on autoimmune thyroid disease

Guzel S. S., DEMİR A., EŞKAZAN T., HATEMİ A. İ., GÖNEN M. S.
Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus) Creative Commons License

2. Clinicopathological Characteristics of Colorectal Neoplasia in Adults Younger than 50 Years: A Real-World Single-Center Study

CANDAN S., Kati O., BAKKALOĞLU O. K., EŞKAZAN T., HATEMİ A. İ., DOBRUCALI A. M., et al.
JOURNAL OF CLINICAL MEDICINE , cilt.15, sa.16, 2026 (SCI-Expanded, Scopus)

3. Noninvasive Detection of Clinically Significant Fibrosis in Biopsy-Proven MASLD: A Retrospective Cross-Sectional Diagnostic Accuracy Study

Eksi O., Atay K., EŞKAZAN T., Abishov E., CANBAKAN M., Canbakan B.
MEDICINA-LITHUANIA , cilt.62, sa.8, 2026 (SCI-Expanded, Scopus)

4. Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study

ÜNAL N. G., BAKKALOĞLU O. K., KAV T., EŞKAZAN T., KANİ H. T., Akpinar A., et al.
INFLAMMATORY BOWEL DISEASES , 2026 (SCI-Expanded, Scopus)

5. Fatigue: The missing target in Crohn’s disease management

EŞKAZAN T., SARIBAŞ A. S., KOCAZEYBEK B. S.
World Journal of Gastroenterology , cilt.32, sa.26, 2026 (SCI-Expanded, Scopus) Creative Commons License

6. Prevalence of Latent and Active Tuberculosis Infection in Inflammatory Bowel Disease Patients Who Received Biological Treatment

DASHDAMIROVA S., EŞKAZAN T., ERZİN Y. Z., ÇELİK A. F., HATEMİ G., HATEMİ A. İ.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.37, sa.5, ss.564-572, 2026 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

7. ANCA-associated vasculitis presenting with tongue necrosis and severe gastrointestinal involvement

Karakoc A., Kopac S., Atas I., ERZİN Y. Z., EŞKAZAN T., Hatipoglu E., et al.
Clinical and Experimental Rheumatology , cilt.44, sa.4, ss.874-875, 2026 (SCI-Expanded, Scopus)

8. Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome

Hod K., Marasco G., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.
Neurogastroenterology and Motility , cilt.38, sa.4, 2026 (SCI-Expanded, Scopus)

9. Transmural Remission Rate Assessed by Intestinal Ultrasound in Crohn’s Disease Patients with Endoscopic Remission

EŞKAZAN T., Ceylan G., Alasgarli S., Akpınar A., KATI O., bakkaloglu o. k., et al.
Cerrahpaşa Medical Journal , sa.1, ss.1-5, 2026 (TRDizin) Creative Commons License

10. Hepatitis B Virus Screening, Prophylaxis, and Reactivation in Inflammatory Bowel Disease Patients Undergoing Biologic Therapy: Real-Life Data from a Tertiary Center in Türkiye

EŞKAZAN T., SONSUZ A.
Cerrahpaşa Medical Journal , sa.1, ss.1-4, 2026 (TRDizin) Creative Commons License

11. Prevalence of Celiac Disease in Autoimmune Liver Diseases

Fidan S., Yaylamaz Kustu S., EŞKAZAN T., Hatemi A. I.
Hepatitis Monthly , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

12. Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities

Marasco G., Hod K., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.
United European Gastroenterology Journal , cilt.13, sa.5, ss.798-818, 2025 (SCI-Expanded, Scopus)

13. Prognostic value of the triglyceride-glucose index in gastric cancer

EŞKAZAN T., SARIBAŞ A. S., KOCAZEYBEK B. S.
World Journal of Gastroenterology , cilt.31, sa.17, 2025 (SCI-Expanded, Scopus)

14. COVID-19 Seroprevalence in Cirrhotic Patients and Effect of COVID-19 Infection on Liver Cirrhosis by Clinical Form in the Postinfectious Period

Oenal U., Oezbey D., Bakkaloglu O. K., EŞKAZAN T., Kurt E. A., HATEMİ A. İ., et al.
ISTANBUL MEDICAL JOURNAL , sa.4, ss.304-310, 2024 (ESCI, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

15. Comparative Value of CRP and FCP for Endoscopic and Histologic Remissions in Ulcerative Colitis

Bakkaloglu O. K., Sen G., KEPİL N., EŞKAZAN T., Kurt E. A., Onal U., et al.
DIAGNOSTICS , cilt.14, sa.20, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP.

Küçükyurt S., EŞKAZAN T., Ayer M., Klllçklran Avcl B., Hatemi I., EŞKAZAN A. E.
Pleura and peritoneum , cilt.9, sa.1, ss.39-43, 2024 (ESCI) Creative Commons License

17. P856 Influential factors on the clinical and radiological closure of resistant perianal fistula treated with stoma

Candan S., Bakkaloglu O. K., Bayar M., Eskazan T., Hatemi I., Erzin Y., et al.
JOURNAL OF CROHN'S AND COLITIS , cilt.1, sa.18, ss.856, 2024 (SCI-Expanded, Scopus)

18. The Role of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Pathogenesis of Ulcerative Colitis and Crohn's Disease

KURT E., Demirci M., Ozbey D., Gareayaghi N., EŞKAZAN T., ERZİN Y. Z., et al.
Clinical Laboratory , cilt.70, sa.1, ss.157-166, 2024 (SCI-Expanded, Scopus)

19. Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver

Ozaslan E., GÜNŞAR F., Ormeci A. C., HATEMİ A. İ., Efe C., AKYOL G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.34, 2023 (SCI-Expanded, Scopus, TRDizin)

20. Increase in transaminase levels during COVID-19 infection and its association with poor prognosis

Bakkaloglu O. K., Onal U., Eskazan T., Kurt E. A., Candan S., Karaali R., et al.
SINGAPORE MEDICAL JOURNAL , cilt.64, sa.10, ss.640-644, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Is There A Connection Between Primary Hypophysitis and Celiac Disease?

Kara Z., EŞKAZAN T., ŞAHİN S., Durcan E., Sulu C., Demir A. N., et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.132, sa.1, ss.33-38, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Does intestinal obstruction influence hypo-albuminemia: assessment of the physio-pathogenesis of protein-losing enteropathy with literature review

Bakkaloglu O. K., Bavunoglu I., Aslan S., Eskazan T., Celik S., Kepil N., et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.27, sa.12, ss.5767-5774, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Partial Atrophy of The Pancreas in Endoscopic Ultrasonography may be a Sign of Pancreatic Cancer

BAKKALOĞLU O. K., EŞKAZAN T., GÜLTÜRK İ., YILDIRIM S., atay k., KEPİL N., et al.
ISTANBUL MEDICAL JOURNAL , sa.2, ss.210-215, 2023 (ESCI, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

24. Long-Term Prognosis of Crohn’s Disease of the Pouch: A Single-Center Experience of 17 Years

Gündoğdu Karaköse T., EŞKAZAN T., KEPİL N., BACA B., HAMZAOĞLU İ., Hatipoglu E., et al.
Cerrahpaşa Medical Journal , cilt.47, sa.1, ss.37-42, 2023 (TRDizin)

25. Comparison of Hospitalized COVID-19 Patients in Terms of Disease Course According to the Presence of Gastrointestinal Symptoms Before and After Admission

KURT E. A., BAKKALOĞLU O. K., EŞKAZAN T., AKDOGAN S., ÖNAL U., CANDAN S., et al.
Turkish Journal of Gastroenterology , cilt.34, sa.4, ss.322-331, 2023 (SCI-Expanded, Scopus, TRDizin)

26. Post COVID-19 irritable bowel syndrome

Marasco G., Cremon C., Barbaro M. R., Cacciari G., Falangone F., Kagramanova A., et al.
Gut , cilt.72, sa.3, ss.484-492, 2023 (SCI-Expanded, Scopus) Creative Commons License

27. Kikuchi Fujimoto disease as the presenting component of VEXAS syndrome: a case report of a probable association

Yılmaz U., Güner S., Eşkazan T., Demiröz A. S., Kurtuluş G., Bahar F., et al.
CLINICAL RHEUMATOLOGY , cilt.41, sa.11, ss.3589-3592, 2022 (SCI-Expanded, Scopus)

28. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

Efe C., Taşçılar K., Gerussi A., Bolis F., Lammert C., Ebik B., et al.
Journal of Autoimmunity , cilt.132, 2022 (SCI-Expanded, Scopus)

29. The Association Between Somatostatin Receptor Ligand and Vitamin B12 in Patients with Acromegaly

ŞAHİN S., EŞKAZAN T., ÇİÇEK E., Ozogul Y. Y., Durcan E., SULU C., et al.
TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , sa.2, ss.67-72, 2022 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

30. The Psychological Effects of COVID-19 Pandemic in Patients with Inflammatory Bowel Disease

EŞKAZAN T., BAKKALOĞLU O. K., DURCAN E., KURT E. A., ÖNAL U., CANDAN S., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.33, sa.5, ss.387-396, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

31. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis

Efe C., Lammert C., Tascilar K., Dhanasekaran R., Ebik B., Higuera-de la Tijera F., et al.
LIVER INTERNATIONAL , cilt.42, sa.3, ss.607-614, 2022 (SCI-Expanded, Scopus)

32. Can we predict mucosal remission in ulcerative colitis more precisely with a redefined cutoff level of C-reactive protein?

BAKKALOĞLU O. K., EŞKAZAN T., Celik S., KURT E. A., HATEMİ A. İ., Erzin Y., et al.
COLORECTAL DISEASE , cilt.24, sa.1, ss.77-84, 2022 (SCI-Expanded, Scopus)

33. Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study

Marasco G., Cremon C., Barbaro M. R., Salvi D., Cacciari G., Kagramanova A., et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.117, sa.1, ss.147-157, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Frequency, Predisposing Factors, and Clinical Outcome of Azathioprine-Induced Pancreatitis Among Patients With Inflammatory Bowel Disease Results From a Tertiary Referral Center

EŞKAZAN T., BOZCAN S., ATAY K., YILDIRIM S., DEMİR N., Celik S., et al.
PANCREAS , cilt.50, sa.9, ss.1274-1280, 2021 (SCI-Expanded, Scopus)

35. The effect of concomitant ankylosing spondylitis on long-term outcome of patients with inflammatory bowel disease

ATAY K., Eyvazov H., BOZCAN S., EŞKAZAN T., DEMİR N., Hatemi I., et al.
Turkish Journal of Gastroenterology , cilt.30, sa.7, ss.599-604, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

36. Coexistence of Hermansky-Pudlak syndrome and JAK2<sup>V617F</sup>-positive essential thrombocythemia.

Eskazan T., Erturkuner S., Isildar B., Eskazan A. E., Ar M. C., Atay K., et al.
Ultrastructural pathology , cilt.43, ss.94-98, 2019 (SCI-Expanded, Scopus)

37. Prevalence of osteoporosis, osteopenia and vitamin d deficiency in cirrhotic patients.

Atay K., Hatemi I., Durcan E., Eskazan T., Bozcan S., SAHUTOGLU T., et al.
BIOMEDICAL RESEARCH-INDIA , cilt.28, sa.6, ss.2631-2635, 2017 (SCI-Expanded, Scopus)

38. Fatal gastrointestinal bleeding and perforated duodenal ulcer: a rare complication of deferasirox in a patient with liver cirrhosis

Atay K., Eskazan T., Salihoglu A., HATEMİ A. İ.
BIOMEDICAL RESEARCH-INDIA , cilt.28, sa.12, ss.5620-5622, 2017 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. Platelet Ultrastructure of Complicated Chron’s-Like Colitis Associated With Hermansky-Pudlak Syndrome

ÇALIŞKAN T., EŞKAZAN A. E., ERTÜRKÜNER S. P., IŞILDAR B., ERZİN Y. Z., BAŞLAR Z., et al.
International Microscopy Congress, Prague, Çek Cumhuriyeti, 7 - 12 Eylül 2014, ss.293, (Tam Metin Bildiri)
Metrikler

Yayın

41

Yayın (WoS)

36

Yayın (Scopus)

34

Atıf (WoS)

235

H-İndeks (WoS)

9

Atıf (Scopus)

251

H-İndeks (Scopus)

8

Atıf (Scholar)

8

H-İndeks (Scholar)

1

Atıf (TrDizin)

4

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

4

Proje

2

Açık Erişim

10
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER